
|Articles|October 15, 2016
- BioPharm International-10-15-2016
- Volume 2016 eBook
- Issue 2
Plant-Made Pharmaceuticals—Accelerating Drug Development Globally
Author(s)Barry Holtz
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Advertisement
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Download the BioPharm International
.
Articles in this issue
over 9 years ago
Cell Line Quality Technologiesover 9 years ago
Investigation Effectiveness Drives Human Performance Excellenceover 9 years ago
Data Integrity Challenges in Manufacturingover 9 years ago
Seeking Accelerated Biosimilar Characterizationover 9 years ago
Testing the BrothNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5





